Torin 1
Based on 133 publication(s) in Google Scholar
Torin 1 is a potent inhibitor of mTOR with an IC50 of 3 nM. Torin 1 inhibits both mTORC1/2 complexes with IC50 values between 2 and 10 nM. Torin 1 is an effective inducer of autophagy.
For research use only. We do not sell to patients.
- Purity: 99.28%
- CAS No.: 1222998-36-8
- Formula: C35H28F3N5O2
- Molecular Weight:607.62
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
Publications Citing Use of MedChemExpress (MCE) Torin 1
More- Signal Transduct Target Ther. 2025 Sep 26;10(1):315. [Abstract]
- Nature. 2026 Jan;649(8098):1022-1031. [Abstract]
- Cell Metab. 2018 Jan 9;27(1):118-135.e8. [Abstract]
- Nat Immunol. 2023 Nov;24(11):1813-1824. [Abstract]
- Cell Stem Cell. 2022 Apr 7;29(4):545-558.e13. [Abstract]
- Nat Cell Biol. 2026 Apr;28(4):812-827. [Abstract]
- Nat Cell Biol. 2025 Sep 22. [Abstract]
- Mol Cell. 2025 Jul 3;85(13):2581-2596.e6. [Abstract]
- Mol Cell. 2022 Aug 4;82(15):2844-2857.e10. [Abstract]
- Cancer Res. 2022 May 16;82(10):1890-1908. [Abstract]
- Nat Commun. 2025 Oct 20;16(1):9250. [Abstract]
- Nat Commun. 2025 Oct 3;16(1):8822. [Abstract]
- Nat Commun. 2025 Jul 1;16(1):5826. [Abstract]
- Nat Commun. 2023 Mar 28;14(1):1726. [Abstract]
- Cell Death Differ. 2025 Jul;32(7):1317-1335. [Abstract]
- Autophagy. 2026 Jun 25:1-16. [Abstract]
- Autophagy. 2025 Jul;21(7):1591-1607. [Abstract]
- Autophagy. 2024 Dec;20(12):2719-2737. [Abstract]
- Autophagy. 2025 Jan;21(1):120-140. [Abstract]
- Autophagy. 2024 Oct;20(10):2221-2237. [Abstract]
- Autophagy. 2024 Aug;20(8):1798-1814. [Abstract]
- Autophagy. 2023 Dec;19(12):3096-3112. [Abstract]
- Autophagy. 2023 Jan;19(1):324-337. [Abstract]
- Autophagy. 2020 Oct;16(10):1786-1806. [Abstract]
- Adv Sci (Weinh). 2025 Jul 25:e15313. [Abstract]
- Nat Chem Biol. 2025 Apr;21(4):490-500. [Abstract]
- Nucleic Acids Res. 2023 May 22;51(9):4415-4428. [Abstract]
- Exp Mol Med. 2025 Aug;57(8):1847-1860. [Abstract]
- Carbohydr Polym. 2023 Nov 1:319:121208. [Abstract]
- Mol Ther. 2022 Oct 5;30(10):3193-3208. [Abstract]
- J Hazard Mater. 2023 Apr 15:448:130785. [Abstract]
- Research (Wash D C). 2024 Mar 27:7:0343. [Abstract]
- J Immunother Cancer. 2020 Sep;8(2):e000517. [Abstract]
- Mol Biomed. 2025 Nov 17;6(1):110. [Abstract]
- Adv Healthc Mater. 2026 Mar 9:e05286. [Abstract]
- Adv Healthc Mater. 2025 Oct 21:e03799. [Abstract]
- Adv Healthc Mater. 2024 Sep 5:e2402357. [Abstract]
- Cell Death Dis. 2023 Oct 13;14(10):676. [Abstract]
- Cell Death Dis. 2019 Nov 18;10(12):872. [Abstract]
- Cell Death Dis. 2018 Oct 9;9(10):1032. [Abstract]
- Cell Death Dis. 2018 May 22;9(6):604. [Abstract]
- Proc Natl Acad Sci U S A. 2022 Jan 18;119(3):e2114134119. [Abstract]
- Cell Commun Signal. 2023 May 24;21(1):120. [Abstract]
- EMBO J. 2025 Oct 20. [Abstract]
- EMBO J. 2025 Apr 7. [Abstract]
- Free Radic Biol Med. 2025 Jun:233:148-161. [Abstract]
- Free Radic Biol Med. 2023 Nov 1:208:402-417. [Abstract]
- Haematologica. 2017 Apr;102(4):755-764. [Abstract]
- Br J Pharmacol. 2025 Aug;182(15):3522-3538. [Abstract]
- Cell Chem Biol. 2026 May 21;33(5):637-648.e10. [Abstract]
- J Natl Cancer Inst. 2023 Nov 8;115(11):1383-1391. [Abstract]
- Cell Death Discov. 2025 Oct 9;11(1):455. [Abstract]
- Cell Rep. 2026 Jun 23;45(6):117520. [Abstract]
- Cell Rep. 2025 Dec 16;45(1):116722. [Abstract]
- Cell Rep. 2021 Jul 20;36(3):109398. [Abstract]
- Cell Rep. 2021 Jul 27;36(4):109434. [Abstract]
- Cell Rep. 2021 Jun 22;35(12):109277. [Abstract]
- Cell Rep. 2019 Aug 20;28(8):1971-1980.e8. [Abstract]
- Sci Signal. 2022 Feb 15;15(721):eabi9983. [Abstract]
- NPJ Regen Med. 2023 Nov 7;8(1):63. [Abstract]
- Oncogenesis. 2022 Mar 7;11(1):12. [Abstract]
- Cell Mol Life Sci. 2022 Aug 29;79(9):501. [Abstract]
- Ecotoxicol Environ Saf. 2026 Jan 15:310:119826. [Abstract]
- Ecotoxicol Environ Saf. 2023 Apr 15:255:114725. [Abstract]
- Biochem Pharmacol. 2023 Sep:215:115636. [Abstract]
- J Ethnopharmacol. 2023 Jun 12:309:116365. [Abstract]
- PLoS Pathog. 2025 May 9;21(5):e1013163. [Abstract]
- PLoS Pathog. 2025 Jan 2;21(1):e1012800. [Abstract]
- Pharmaceuticals (Basel). 2024 Sep 28;17(10):1295. [Abstract]
- Front Pharmacol. 2022 Sep 26:13:925489. [Abstract]
- mBio. 2025 Feb 7:e0322624. [Abstract]
- Molecules. 2020 Apr 23;25(8):1980. [Abstract]
- Exp Neurol. 2023 Jun:364:114380. [Abstract]
- iScience. 2025 Nov 30.
- J Lipid Res. 2024 Nov 4:100692. [Abstract]
- J Cell Physiol. 2021 Dec;236(12):8110-8121. [Abstract]
- J Cell Physiol. 2020 Jul;235(7-8):5764-5776. [Abstract]
- Sci Rep. 2025 Oct 22;15(1):36952. [Abstract]
- J Biol Chem. 2023 May;299(5):104621. [Abstract]
- Aging. 2020 Nov 20;12(23):24208-24218. [Abstract]
- J Virol. 2024 Nov 27:e0146324. [Abstract]
- Clin Immunol. 2022 Dec:245:109141. [Abstract]
- Neurochem Res. 2018 Nov;43(11):2141-2154. [Abstract]
- J Virol. 2018 Jul 31;92(16). pii: e00600-18. [Abstract]
- Cell Signal. 2021 Apr:80:109900. [Abstract]
- PLoS Genet. 2019 Apr 10;15(4):e1008077. [Abstract]
- Development. 2024 Nov 1;151(21):dev202899. [Abstract]
- Vet Res. 2025 Jan 31;56(1):23. [Abstract]
- Exp Cell Res. 2018 Jun 15;367(2):186-195. [Abstract]
- Eur J Med Res. 2025 Aug 4;30(1):704. [Abstract]
- BMC Cancer. 2024 Jul 26;24(1):902. [Abstract]
- Mol Carcinog. 2026 May 15. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2026 Jan 15. [Abstract]
- FEBS Lett. 2021 Feb;595(4):462-475. [Abstract]
- Metallomics. 2019 Jul 17;11(7):1200-1206. [Abstract]
- J Orthop Surg Res.2024 May 29;19(1):321. [Abstract]
- Vet Microbiol. 2025 May 13:306:110562. [Abstract]
- Mol Cell Biol. 2019 Jul 29;39(16):e00024-19. [Abstract]
- Mol Cell Biol. 2017 Jun 29;37(14). pii: e00075-17. [Abstract]
- PLoS One. 2019 Feb 4;14(2):e0211727. [Abstract]
- Biochem Biophys Res Commun. 2026 Jul 2:820:153847. [Abstract]
- J Ocul Pharmacol Ther. 2022 Jun;38(5):331-338. [Abstract]
- J Stomatol Oral Maxillofac Surg. 2025 Jul 25:102511. [Abstract]
- FASEB Bioadv. 2025 Jan 7;7(2):e1488. [Abstract]
- Chemotherapy. 2021;66(5-6):169-178. [Abstract]
- bioRxiv. 2026 Jun 7.
- bioRxiv. 2026 May 26.
- bioRxiv. 2026 Mar 5:2026.03.03.709370. [Abstract]
- Indiana University. 2025 Oct.
- bioRxiv. 2025 Nov 20.
- bioRxiv. 2025 Oct 31.
- bioRxiv. 2025 Aug 31:2025.08.26.672367. [Abstract]
- Res Sq. 2025 Sep 25:rs.3.rs-7481614. [Abstract]
- bioRxiv. 2025 Sep 12.
- bioRxiv. 2025 Aug 27:2025.08.26.672159. [Abstract]
- University of Verona. 2025.
- bioRxiv. 2025 Feb 1:2025.01.30.635746. [Abstract]
- University of Verona. 2025.
- Res Sq. 2024 Nov 1:rs.3.rs-5329081. [Abstract]
- bioRxiv. 2024 July 20.
- Res Sq. 2024 Jun 10.
- biorxiv. 2024 Jun 06.
- bioRxiv. 2024 May 22.
- bioRxiv. 2024 Mar 13:2024.03.08.584103. [Abstract]
- bioRxiv. 2023 Sep 7.
- SSRN. 2023 Apr 10.
- SSRN. 2023 Feb 27.
- Research Square Preprint. 2022 Jun.
- Research Square Preprint. 2022 May.
- Oxid Med Cell Longev. 2021 Jul 27;2021:7356266. [Abstract]
- Research Square Preprint. 2021 Jul.
- Research Square Preprint. 2021 May.
- Harvard Medical School LINCS LIBRARY
-
WB
-
WB
-
WB
-
WB
-
WB
Biological Activity
|
mTOR 3 nM (IC50) |
mTORC1 2-10 nM (IC50) |
mTORC2 2-10 nM (IC50) |
ATM 0.6 μM (IC50) |
DNA-PK 1 μM (IC50) |
PI3K-α 1.8 μM (IC50) |
hVps34 3 μM (IC50) |
Autophagy |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | IC50 |
10 nM
Compound: 14
|
Inhibition of N-terminally FLAG-tagged mTORC2 (unknown origin) expressed in human HeLa cells using S6K1 or Akt1 as substrate after 20 mins by immunoblotting assay
Inhibition of N-terminally FLAG-tagged mTORC2 (unknown origin) expressed in human HeLa cells using S6K1 or Akt1 as substrate after 20 mins by immunoblotting assay
|
[PMID: 29211480] |
| PC-3 | EC50 |
1800 nM
Compound: 1, Torin1
|
Inhibition of PI3Kalpha in human PC3 cells expressing Akt1 S473D mutant assessed as phosphorylation of Akt Thr308 by immunoblotting
Inhibition of PI3Kalpha in human PC3 cells expressing Akt1 S473D mutant assessed as phosphorylation of Akt Thr308 by immunoblotting
|
[PMID: 21322566] |
Torin1 (250 nM) completely inhibits proliferation and causes a G1/S cell cycle arrest, and decreases cell size to a greater degree than 50 nM rapamycin in wild-type MEFs[1]. Torin1 has more than 800-fold selectivity between mTOR and PI3Kis, and is very selective relative to other PIKK family kinases with the exception of DNA-PK[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1222998-36-8
-
Appearance Solid
-
Molecular Weight 607.62
-
Formula C35H28F3N5O2
-
Color Light yellow to yellow
-
SMILES
O=C1N(C2=C(C=C1)C=NC3=CC=C(C=C32)C4=CC5=CC=CC=C5N=C4)C6=CC=C(C(C(F)(F)F)=C6)N7CCN(CC7)C(CC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 1 year -20°C 6 months
Publications (133)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
A two-strata energy flux system driven by a stress hormone prioritizes cardiac energetics. [Abstract]2025 Sep 26;10(1):315. PMID: 40998786 -
Nature
2026 Jan;649(8098):1022-1031. PMID: 41225001 -
Cell Metab
mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis. [Abstract]2018 Jan 9;27(1):118-135.e8. PMID: 29275959 -
Nat Immunol
The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity. [Abstract]2023 Nov;24(11):1813-1824. PMID: 37813965 -
Cell Stem Cell
A small-molecule cocktail promotes mammalian cardiomyocyte proliferation and heart regeneration. [Abstract]2022 Apr 7;29(4):545-558.e13. PMID: 35395187 -
Nat Cell Biol
TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy. [Abstract]2026 Apr;28(4):812-827. PMID: 41803502 -
Nat Cell Biol
2025 Sep 22. PMID: 40983659 -
Mol Cell
2025 Jul 3;85(13):2581-2596.e6. PMID: 40555234 -
Mol Cell
2022 Aug 4;82(15):2844-2857.e10. PMID: 35662396 -
Cancer Res
Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. [Abstract]2022 May 16;82(10):1890-1908. PMID: 35315913 -
Nat Commun
Mitochondrial one-carbon metabolism is required for TGF-β-induced glycine synthesis and fibrotic responses. [Abstract]2025 Oct 20;16(1):9250. PMID: 41115888 -
Nat Commun
SFPQ-TFE3 reciprocally regulates mTORC1 and induces lineage plasticity in a mouse model of renal tumorigenesis. [Abstract]2025 Oct 3;16(1):8822. PMID: 41044182 -
Nat Commun
DRAM1 promotes the stability of lysosomal VAMP8 to enhance autolysosome formation and facilitates the extravasation. [Abstract]2025 Jul 1;16(1):5826. PMID: 40595569 -
Nat Commun
Domain-specific p53 mutants activate EGFR by distinct mechanisms exposing tissue-independent therapeutic vulnerabilities. [Abstract]2023 Mar 28;14(1):1726. PMID: 36977662 -
Cell Death Differ
TRIM21-driven K63-linked ubiquitination of RBM38c, as a novel interactor of BECN1, contributes to DNA damage-induced autophagy. [Abstract]2025 Jul;32(7):1317-1335. PMID: 40133668 -
Autophagy
Efficient pharmacological modulation of autophagy in isolated muscle fibers: impact on excitation-contraction coupling. [Abstract]2026 Jun 25:1-16. PMID: 42329081 -
Autophagy
2025 Jul;21(7):1591-1607. PMID: 39952286 -
Autophagy
ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation. [Abstract]2024 Dec;20(12):2719-2737. PMID: 39087410 -
Autophagy
Macrophage autophagy protects against acute kidney injury by inhibiting renal inflammation through the degradation of TARM1. [Abstract]2025 Jan;21(1):120-140. PMID: 39193910 -
Autophagy
PLK2-mediated phosphorylation of SQSTM1 S349 promotes aggregation of polyubiquitinated proteins upon proteasomal dysfunction. [Abstract]2024 Oct;20(10):2221-2237. PMID: 39316746 -
Autophagy
The mammalian actin elongation factor ENAH/MENA contributes to autophagosome formation via its actin regulatory function. [Abstract]2024 Aug;20(8):1798-1814. PMID: 38705725 -
Autophagy
2023 Dec;19(12):3096-3112. PMID: 37471002 -
Autophagy
Stimulating the autophagic-lysosomal axis enhances host defense against fungal infection in a zebrafish model of invasive Aspergillosis. [Abstract]2023 Jan;19(1):324-337. PMID: 35775203 -
Autophagy
STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I. [Abstract]2020 Oct;16(10):1786-1806. PMID: 31696776 -
Adv Sci (Weinh)
Activation of Lysosomal Retrograde Transport Triggers TPC1-IP3R1 Ca2+ Crosstalk at Lysosome-ER MCSs Leading to Lethal Depleting of ER Calcium. [Abstract]2025 Jul 25:e15313. PMID: 40709664 -
Nat Chem Biol
2025 Apr;21(4):490-500. PMID: 39215100 -
Nucleic Acids Res
Translation regulation of specific mRNAs by RPS26 C-terminal RNA-binding tail integrates energy metabolism and AMPK-mTOR signaling. [Abstract]2023 May 22;51(9):4415-4428. PMID: 37013984 -
Exp Mol Med
2025 Aug;57(8):1847-1860. PMID: 40855114 -
Carbohydr Polym
Agrocybe cylindracea fucoglucogalactan induced lysosome-mediated apoptosis of colorectal cancer cell through H3K27ac-regulated cathepsin D. [Abstract]2023 Nov 1:319:121208. PMID: 37567726 -
Mol Ther
Apoptotic vesicles activate autophagy in recipient cells to induce angiogenesis and dental pulp regeneration. [Abstract]2022 Oct 5;30(10):3193-3208. PMID: 35538661 -
J Hazard Mater
Tributyltin chloride (TBTCL) induces cell injury via dysregulation of endoplasmic reticulum stress and autophagy in Leydig cells. [Abstract]2023 Apr 15:448:130785. PMID: 36860030 -
Research (Wash D C)
Fut2 Deficiency Promotes Intestinal Stem Cell Aging by Damaging Mitochondrial Functions via Down-Regulating α1,2-Fucosylation of Asah2 and Npc1. [Abstract]2024 Mar 27:7:0343. PMID: 38550777 -
J Immunother Cancer
Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression. [Abstract]2020 Sep;8(2):e000517. PMID: 32948650 -
Mol Biomed
ER stress induced extracellular vesicles secretion from macrophages promotes calcium oxalate crystals formation in kidney. [Abstract]2025 Nov 17;6(1):110. PMID: 41247622 -
Adv Healthc Mater
Prussian Blue Nanozyme Disrupts the Self-Reinforcing Loop of Tauopathy via Triple-Action Mechanism. [Abstract]2026 Mar 9:e05286. PMID: 41797478 -
Adv Healthc Mater
Inducing In Situ Functional Maturation of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Establishing Strategies for Treating Myocardial Injury. [Abstract]2025 Oct 21:e03799. PMID: 41121551 -
Adv Healthc Mater
Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier-Free Nanodrugs for Breast Cancer Immunotherapy. [Abstract]2024 Sep 5:e2402357. PMID: 39235716 -
Cell Death Dis
Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells. [Abstract]2023 Oct 13;14(10):676. PMID: 37833290 -
Cell Death Dis
FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival. [Abstract]2019 Nov 18;10(12):872. PMID: 31740658 -
Cell Death Dis
Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma. [Abstract]2018 Oct 9;9(10):1032. PMID: 30302016
Torin 1 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2018 Oct 9;9(10):1032. [Abstract]
Western blot showing the cell cycle and autophagy-related proteins after 48 h of treatment with 200 μM NSC 697855 (NTZ) and/or 500 nM Torin 1 or 30 mM Chloroquine (CQ).
-
Cell Death Dis
The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses. [Abstract]2018 May 22;9(6):604. PMID: 29789637
Torin 1 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2018 May 22;9(6):604. [Abstract]
AGS cells are pretreated with 25 and 50 nM PS-341 for 1 h, and then incubated with 500 nM Torin 1 for 24 h. After pretreatment with PPI for 24 h in pH 7.4 or pH 6.5 condition, Rapamycin (1 μM) or Torin 1 (500 nM) is added for another 24 h. The protein level of SQSTM1 is measured by western blot analysis.
-
Proc Natl Acad Sci U S A
2022 Jan 18;119(3):e2114134119. PMID: 35027451 -
Cell Commun Signal
Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles. [Abstract]2023 May 24;21(1):120. PMID: 37226246 -
EMBO J
2025 Oct 20. PMID: 41116059 -
EMBO J
Interferon-induced PARP14-mediated ADP-ribosylation in p62 bodies requires the ubiquitin-proteasome system. [Abstract]2025 Apr 7. PMID: 40195501 -
Free Radic Biol Med
Autophagy and Endoplasmic Reticulum Stress-Related Protein Homeostasis Links Palmitic Acid to Hepatic Lipotoxicity in Zebrafish (Danio rerio), Counteracted by Linoleic Acid. [Abstract]2025 Jun:233:148-161. PMID: 40089081 -
Free Radic Biol Med
Phosphatidylethanolamine alleviates OX-LDL-induced macrophage inflammation by upregulating autophagy and inhibiting NLRP1 inflammasome activation. [Abstract]2023 Nov 1:208:402-417. PMID: 37660837 -
Haematologica
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas. [Abstract]2017 Apr;102(4):755-764. PMID: 28104700
Torin 1 purchased from MedChemExpress. Usage Cited in: Haematologica. 2017 Apr;102(4):755-764. [Abstract]
Knocking out of 4EBPs induces resistance to TORKi treatment. Ramos is transduced with CRISPR-CAS9 vectors targeting both 4EPB1 and 4EBP2 and immunoblotted with the indicated antibodies. 48 h after treatment with AZD8055 or Torin1, 4EBP1/2 double knock-out (Ramos-DKO) and control (Ramos-C) Ramos cells are immunoblotted with antibodies against MCL1 and BCL-XL
-
Br J Pharmacol
Activation of autophagy mediated by PI3K/Akt/mTOR signalling cascade alleviates impaired adipose-derived stem cell osteogenesis in a diabetic microenvironment. [Abstract]2025 Aug;182(15):3522-3538. PMID: 40170369 -
Cell Chem Biol
Mechanism by which a linoleic acid metabolite suppresses cancer cell growth by inhibiting mTOR. [Abstract]2026 May 21;33(5):637-648.e10. PMID: 42066774 -
J Natl Cancer Inst
Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancers. [Abstract]2023 Nov 8;115(11):1383-1391. PMID: 37481710 -
Cell Death Discov
CRISPR-Cas9 screening reveals G2E3 as a novel ubiquitin-linked factor controlling autophagosome-lysosome fusion and cancer cell progression. [Abstract]2025 Oct 9;11(1):455. PMID: 41068090 -
Cell Rep
Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. [Abstract]2026 Jun 23;45(6):117520. PMID: 42284146 -
Cell Rep
Liprin-α1 enhances PHLDB3 oncogenic function in colorectal cancer via activation of mTORC2-AKT1 pathway. [Abstract]2025 Dec 16;45(1):116722. PMID: 41405991 -
Cell Rep
Neuronal activity recruits the CRTC1/CREB axis to drive transcription-dependent autophagy for maintaining late-phase LTD. [Abstract]2021 Jul 20;36(3):109398. PMID: 34289350 -
Cell Rep
SAC1 regulates autophagosomal phosphatidylinositol-4-phosphate for xenophagy-directed bacterial clearance. [Abstract]2021 Jul 27;36(4):109434. PMID: 34320354 -
Cell Rep
TOR signaling regulates liquid phase separation of the SMN complex governing snRNP biogenesis. [Abstract]2021 Jun 22;35(12):109277. PMID: 34161763 -
Cell Rep
2019 Aug 20;28(8):1971-1980.e8. PMID: 31433975 -
Sci Signal
2022 Feb 15;15(721):eabi9983. PMID: 35167340 -
NPJ Regen Med
Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment. [Abstract]2023 Nov 7;8(1):63. PMID: 37935709 -
Oncogenesis
2022 Mar 7;11(1):12. PMID: 35256584 -
Cell Mol Life Sci
The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates. [Abstract]2022 Aug 29;79(9):501. PMID: 36036324 -
Ecotoxicol Environ Saf
Florasulam impairs Leydig cell function by blocking autophagic flux and triggering PERK-eIF2α-ATF4-CHOP-mediated ER stress. [Abstract]2026 Jan 15:310:119826. PMID: 41643304 -
Ecotoxicol Environ Saf
2023 Apr 15:255:114725. PMID: 36924558 -
Biochem Pharmacol
Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells. [Abstract]2023 Sep:215:115636. PMID: 37290598 -
J Ethnopharmacol
2023 Jun 12:309:116365. PMID: 36907478 -
PLoS Pathog
SIRT5-mediated desuccinylation of the porcine deltacoronavirus M protein drives pexophagy to enhance viral proliferation. [Abstract]2025 May 9;21(5):e1013163. PMID: 40344161 -
PLoS Pathog
2025 Jan 2;21(1):e1012800. PMID: 39746094 -
Pharmaceuticals (Basel)
Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis. [Abstract]2024 Sep 28;17(10):1295. PMID: 39458936 -
Front Pharmacol
GSK3β-dependent lysosome biogenesis: An effective pathway to mitigate renal fibrosis with LM49. [Abstract]2022 Sep 26:13:925489. PMID: 36225562 -
mBio
Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential. [Abstract]2025 Feb 7:e0322624. PMID: 39918313 -
Molecules
In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei. [Abstract]2020 Apr 23;25(8):1980. PMID: 32340370 -
Exp Neurol
Exercise pretreatment alleviates neuroinflammation and oxidative stress by TFEB-mediated autophagic flux in mice with ischemic stroke. [Abstract]2023 Jun:364:114380. PMID: 36914085 -
-
J Lipid Res
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells. [Abstract]2024 Nov 4:100692. PMID: 39505261 -
J Cell Physiol
2021 Dec;236(12):8110-8121. PMID: 34101831 -
J Cell Physiol
IFN-γ/mTORC1 decreased Rab11 in Schwann cells of diabetic peripheral neuropathy, inhibiting cell proliferation via GLUT1 downregulation. [Abstract]2020 Jul;235(7-8):5764-5776. PMID: 31970777 -
Sci Rep
Lysosomal homeostasis regulates myocardial ischemia-reperfusion injury through autophagy pathway. [Abstract]2025 Oct 22;15(1):36952. PMID: 41125732 -
J Biol Chem
TRIM28 represses renal cell carcinoma cell proliferation by inhibiting TFE3/KDM6A-regulated autophagy. [Abstract]2023 May;299(5):104621. PMID: 36935008 -
Aging
2020 Nov 20;12(23):24208-24218. PMID: 33223507 -
J Virol
2024 Nov 27:e0146324. PMID: 39601560 -
Clin Immunol
Diabetes mellitus aggravates humoral immune response in myasthenia gravis by promoting differentiation and activation of circulating Tfh cells. [Abstract]2022 Dec:245:109141. PMID: 36270469 -
Neurochem Res
DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells. [Abstract]2018 Nov;43(11):2141-2154. PMID: 30229399
Torin 1 purchased from MedChemExpress. Usage Cited in: Neurochem Res. 2018 Nov;43(11):2141-2154. [Abstract]
Torin 1 (T) stimulation decreases the ratios of phospho-mTOR (Ser 2448)/ mTOR, phospho-S6K1 (Thr 389)/S6K1 and NGF/β-actin at all time points.
-
J Virol
Porcine Reproductive and Respiratory Syndrome Virus Infection Induces both eIF2α Phosphorylation-Dependent and -Independent Host Translation Shutoff. [Abstract]2018 Jul 31;92(16). pii: e00600-18. PMID: 29899101
Torin 1 purchased from MedChemExpress. Usage Cited in: J Virol. 2018 Jul 31;92(16). pii: e00600-18. [Abstract]
HEK293T cells treated with Torin 1 (250 nM, 6 h) are used as the positive control. The cells are harvested at 30 h posttransfection and the lysates are analyzed with immunoblotting using antibodies specific for the indicated proteins.
-
Cell Signal
Akt phosphorylation regulated by IKKε in response to low shear stress leads to endothelial inflammation via activating IRF3. [Abstract]2021 Apr:80:109900. PMID: 33370582 -
PLoS Genet
Novel AU-rich proximal UTR sequences (APS) enhance CXCL8 synthesis upon the induction of rpS6 phosphorylation. [Abstract]2019 Apr 10;15(4):e1008077. PMID: 30969964 -
Development
Axin1 regulates tooth root development by inhibiting AKT1-mTORC1 activation and Shh translation in Hertwig's epithelial root sheath. [Abstract]2024 Nov 1;151(21):dev202899. PMID: 39344774 -
Vet Res
The cholesterol metabolite 25-hydroxycholesterol suppresses porcine deltacoronavirus via lipophagy inhibition and mTORC1 modulation. [Abstract]2025 Jan 31;56(1):23. PMID: 39891192 -
Exp Cell Res
Hyperglycemia-induced Bcl-2/Bax-mediated apoptosis of Schwann cells via mTORC1/S6K1 inhibition in diabetic peripheral neuropathy. [Abstract]2018 Jun 15;367(2):186-195. PMID: 29621478
Torin 1 purchased from MedChemExpress. Usage Cited in: Exp Cell Res. 2018 Jun 15;367(2):186-195. [Abstract]
Torin1 and Rapamycin downregulate phospho-mTOR (Ser 2448), phospho-S6K1 (Thr 389), phospho-4EBP1 (Thr 37/46), Bcl-2 and upregulate Bax, cleaved caspase-3 in vitro cultured RSC96 cells.
-
Eur J Med Res
Long non-coding RNA NORAD serves as a promoter of oncogenesis and inhibits ferroptosis via miR-144-3p-mTOR-ferritinophagy axis in cancer. [Abstract]2025 Aug 4;30(1):704. PMID: 40760677 -
BMC Cancer
2024 Jul 26;24(1):902. PMID: 39061024 -
Mol Carcinog
LKB1 Loss Sensitizes Lung Tumor Spheres to Mitomet-Induced Ferroptosis, and These Effects are Enhanced by mTOR Inhibition. [Abstract]2026 May 15. PMID: 42138621 -
Naunyn Schmiedebergs Arch Pharmacol
Morusin attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis via dual activation of the Nrf2/HO-1 pathway and mTORC1-dependent GPX4 synthesis. [Abstract]2026 Jan 15. PMID: 41538060 -
FEBS Lett
mTORC1-mediated amino acid signaling is critical for cell fate determination under transplant-induced stress. [Abstract]2021 Feb;595(4):462-475. PMID: 33249578 -
Metallomics
AMPK mediates the neurotoxicity of iron oxide nanoparticles retained in mitochondria or lysosomes. [Abstract]2019 Jul 17;11(7):1200-1206. PMID: 31241124 -
J Orthop Surg Res
mTOR mutation disrupts larval zebrafish tail fin regeneration via regulating proliferation of blastema cells and mitochondrial functions. [Abstract]2024 May 29;19(1):321. PMID: 38812038 -
Vet Microbiol
Porcine reproductive and respiratory syndrome virus nsp2-related proteins induce host translational arrest by specifically impairing the mTOR signaling cascade. [Abstract]2025 May 13:306:110562. PMID: 40367705 -
Mol Cell Biol
2019 Jul 29;39(16):e00024-19. PMID: 31160490 -
Mol Cell Biol
An In Vitro TORC1 Kinase Assay That Recapitulates the Gtr-Independent Glutamine-Responsive TORC1 Activation Mechanism on Yeast Vacuoles. [Abstract]2017 Jun 29;37(14). pii: e00075-17. PMID: 28483912
Torin 1 purchased from MedChemExpress. Usage Cited in: Mol Cell Biol. 2017 Jun 29;37(14). pii: e00075-17. [Abstract]
L-glutamine-responsive TORC1 activation in vitro. An in vitro kinase assay using semi-intact cells is performed. The reaction is performed with or without the indicated amount of Rapamycin or Torin-1. FLAG-tagged Tor1 and Myc-tagged Kog1 are detected as loading controls. The bar graph refers to the mean ratio of phosphorylated/total 4EBP1, normalized to the values for the DMSO-treated and glutamine-unadded samples.
-
PLoS One
Fluctuations in cell density alter protein markers of multiple cellular compartments, confounding experimental outcomes. [Abstract]2019 Feb 4;14(2):e0211727. PMID: 30716115 -
Biochem Biophys Res Commun
Evaluation of autophagy effector proteins for targeted protein degradation using chemically induced proximity. [Abstract]2026 Jul 2:820:153847. PMID: 42054895 -
J Ocul Pharmacol Ther
Autophagy Protects Ocular Surface Against Overactivated Inflammation by Degrading Retinoic Acid-Induced Gene-I in Human Conjunctival Epithelial Cells. [Abstract]2022 Jun;38(5):331-338. PMID: 35613408 -
J Stomatol Oral Maxillofac Surg
Protective role of interleukin-37 in oral lichen planus: Regulation of Jurkat cell glycolysis through the mTOR pathway. [Abstract]2025 Jul 25:102511. PMID: 40714261 -
FASEB Bioadv
2025 Jan 7;7(2):e1488. PMID: 39917394 -
Chemotherapy
The Synergistic Inhibitory Effect of Combining MK-2206 and AZD 6244 in MARIMO Cells Harboring a Calreticulin Gene Mutation. [Abstract]2021;66(5-6):169-178. PMID: 34666331 -
-
-
bioRxiv
Intrinsically disordered SERBP1 regulates translation through topology-driven G-quadruplex recognition. [Abstract]2026 Mar 5:2026.03.03.709370. PMID: 41846982 -
-
-
-
bioRxiv
Replating induces mTOR-dependent rescue of protein synthesis in Charcot-Marie-Tooth diseased neurons. [Abstract]2025 Aug 31:2025.08.26.672367. PMID: 40909707 -
Res Sq
Persistent mTORC1 activation underlies sex dimorphic progression of MASLD in mice with hepatocyte prohibitin-1 deficiency. [Abstract]2025 Sep 25:rs.3.rs-7481614. PMID: 41041578 -
-
bioRxiv
2025 Aug 27:2025.08.26.672159. PMID: 40909729 -
-
bioRxiv
2025 Feb 1:2025.01.30.635746. PMID: 39975205 -
-
Res Sq
Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma. [Abstract]2024 Nov 1:rs.3.rs-5329081. PMID: 39574899 -
-
-
-
-
bioRxiv
Transcriptional Regulation of Protein Synthesis by Mediator Kinase in MYC-driven Medulloblastoma. [Abstract]2024 Mar 13:2024.03.08.584103. PMID: 38559100 -
-
-
-
-
-
Oxid Med Cell Longev
Deficiency of ROS-Activated TRPM2 Channel Protects Neurons from Cerebral Ischemia-Reperfusion Injury through Upregulating Autophagy. [Abstract]2021 Jul 27;2021:7356266. PMID: 34367466 -
-
-
Harvard Medical School LINCS LIBRARY
Solvent & Solubility
DMSO : 2 mg/mL (3.29 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 1% DMSO 99% Saline
Solubility: 0.05 mg/mL (0.08 mM); Suspended solution; Need ultrasonic
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
To produce soluble mTORC1, HEK-293T cell lines are generated that stably express N-terminally FLAG-tagged Raptor using vesicular stomatitis virus G-pseudotyped MSCV retrovirus. For mTORC2, HeLa cells are generated that stably express N-terminally FLAG-tagged Protor-1. Both complexes are purified by lysing cells in 50 mM HEPES, pH 7.4, 10 mM sodium pyrophosphate, 10 mM sodium β-glycerophosphate, 100 mM NaCl, 2 mM EDTA, 0.3% CHAPS. Cells are lysed at 4°C for 30 min, and the insoluble fraction is removed by microcentrifugation at 13,000 rpm for 10 min. Supernatants are incubated with FLAG-M2 monoclonal antibody-agarose for 1 h and then washed three times with lysis buffer and once with lysis buffer containing a final concentration of 0.5 mol/L NaCl. Purified mTORC1 is eluted with 100 μg/mL 3× FLAG peptide in 50 mM HEPES, pH 7.4, 100 mM NaCl. Eluate can be aliquoted and stored at -80°C. Kinase assays are performed for 20 min at 30°C in a final volume of 20 μL consisting of the kinase buffer (25 mM HEPES, pH 7.4, 50 mM KCl, 10 mM MgCl2, 500 μM ATP) and 150 ng of inactive S6K1 or Akt1 as substrates. Reactions are stopped by the addition of 80 μL of sample buffer and boiled for 5 min. Samples are subsequently analyzed by SDS-PAGE and immunoblotting.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
On Day 0, 96-well plates are seeded with 500 cells per well and grown overnight. On Day 1, cells are treated with the appropriate compounds and subsequently analyzed on Days 3-5. For analysis, plates are incubated for 60 min at room temperature; 50 μL of CellTiter-Glo reagent is added to each well, and plates are mixed on an orbital shaker for 12 min. Luminescence is quantified on a standard plate luminometer.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
For pharmacodynamic experiments, torin 1 powder is first dissolved at 25 mg/mL in 100% N-methyl-2-pyrrolidone and then diluted 1:4 with sterile 50% PEG400 prior to injection. Six-week old male C57BL/6 mice are fasted overnight prior to drug treatment. The mice are treated with vehicle (for 10 hr) or 26 (20 mg/kg for 2, 6 or 10 hr) by IP injection, and then refed 1 h prior to sacrifice (CO2 asphyxiation). Tissues are collected and frozen on dry ice. The frozen tissue is thawed on ice and lysed by sonication in tissue lysis buffer (50 mM HEPES, pH 7.4, 40 mM NaCl, 2 mM EDTA, 1.5 mM sodium orthovanadate, 50 mM sodium fluoride, 10 mM sodium pyrophosphate, 10 mM sodium β-glycerophosphate, 0.1% SDS, 1.0% sodium deoxycholate and 1.0% Triton, supplemented with protease inhibitor cocktail tablets). The concentration of clear lysate is measured using the Bradford assay and samples are subsequently normalized by protein content and analyzed by SDS-PAGE and immunoblotting.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (287 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Thoreen CC, et al, An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem, 2009, 284(12), 8023-8032. [Content Brief]
[2]. Liu Q, et al. Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer. J Med Chem. 2010 Oct 14;53(19):7146-55. [Content Brief]
[3]. Bi C, et al. Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas. Haematologica. 2017 Apr;102(4):755-764. [Content Brief]
[4]. Brandt M, et al. mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis. Cell Metab. 2018 Jan 9;27(1):118-135.e8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.6458 mL | 8.2288 mL | 16.4577 mL | 41.1441 mL |